Physiogenex invites you to attend its new webinar
presented by our expert Dr. François Briand on Thursday, March the 17th 2022 at 5pm CET, 11am EST, 8am PST:
Optimize your drug development with novel animal models of human nonalcoholic steatohepatitis

Register here

Not available to attend?

Feel free to contact us if you wish to set-up an appointment with Dr. Briand and/or discuss your drug development projects with us.

About us

Physiogenex is a leading preclinical research organization providing non clinical services in metabolic disorders and complications.

We offer in vivo translational diseases models as well as ex vivo assays to support efficacy and pharmacological assays. We have a strong expertise on metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, liver diseases (NASH to fibrosis), cardiovascular and renal complications.